Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of Treatment

INTRODUCTION: Exenatide is gradually released from exenatide once weekly (QW) microspheres, and at steady state, consistently controls glycated hemoglobin (HbA1c) in patients with type 2 diabetes (T2D). This post hoc analysis examined the timing to onset of clinical responses and their correlations...

Descripción completa

Detalles Bibliográficos
Autores principales: Blevins, Thomas, Ruggles, James, Hardy, Elise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900982/
https://www.ncbi.nlm.nih.gov/pubmed/27146799
http://dx.doi.org/10.1007/s13300-016-0172-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900982/
https://www.ncbi.nlm.nih.gov/pubmed/27146799
http://dx.doi.org/10.1007/s13300-016-0172-0

Ejemplares similares